BD BBL™ CDC Anaerobe Blood Agar With Kanamycin And Vancomycin 221736Recalls & reported problems
Becton, Dickinson And Company · BD BBL™ CDC Anaerobe Blood Agar With Kanamycin And Vancomycin, 100 plates · Class 1
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10382902217364), received between Jul 29, 2022 and Jul 29, 2022 — classified as 1 malfunction.
The most frequently reported specific device problem is “Contamination” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Contamination1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionJul 29, 2022Contamination; Contamination
IT WAS REPORTED THAT WHILE USING 100 BD BBL CDC ANAEROBE 5% SHEEP BLOOD AGAR WITH KANAMYCIN AND VANCOMYCIN (KV) BACTERIAL CONTAMINATION WAS OBSERVED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "BACTERIAL (BASED ON PHOTO REVIEW)".
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 15135834 ↗
Other CULTURE MEDIA, SELECTIVE AND NON-DIFFERENTIAL devices
- BD BBL™ Phenylethyl Alcohol Agar with 5% Sheep Blood 221277Becton, Dickinson And Company · CULTURE MEDIA, SELECTIVE AND NON-DIFFERENTIAL303 reports
- REMEL R01272Remel, Inc. · Culture Media, Selective And Non-Differential1 recall0 reports
- REMEL R01144Remel, Inc. · Culture Media, Selective And Non-Differential1 recall0 reports
- BD BBL™ Inhibitory Mold Agar Deep Fill 298191Becton, Dickinson And Company · CULTURE MEDIA, SELECTIVE AND NON-DIFFERENTIAL40 reports
- BD BBL™ Columbia CNA Agar with 5% Sheep Blood 221353Becton, Dickinson And Company · CULTURE MEDIA, SELECTIVE AND NON-DIFFERENTIAL9 reports
- BD BBL™ XLD Agar 221284Becton, Dickinson And Company · CULTURE MEDIA, SELECTIVE AND NON-DIFFERENTIAL9 reports
- BD BBL™ Lowenstein-Jensen Medium, Gruft, Slants 297653Becton, Dickinson And Company · CULTURE MEDIA, SELECTIVE AND NON-DIFFERENTIAL5 reports
- BD BBL™ Middlebrook and Cohn 7H10 Agar Slants 220958Becton, Dickinson And Company · CULTURE MEDIA, SELECTIVE AND NON-DIFFERENTIAL2 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page